TRVN Stock Price: Trevena Inc shares take a dive after common stock offering

The TRVN stock price has fallen 17% after the company floated more shares on Wednesday.
There are some good support levels around and the bulls will be watching them closely.

FXStreet Team FXStreet

TRVN stock forecast

Shares in Trevena NASDAQ:TRVN have taken a sharp fall after the company announced underwritten public offering of 21,739,131 shares of its common stock at a public offering price of $2.30 per share. This was despite the stock trading at USD 2.72 per share at the close on Tuesday. The price of TRVN stock pushed after higher the FDA approved OLINVYK in adults for the management of acute pain severe enough to require an intravenous opioid analgesic. In essence, Olinvyk is an opioid pain medicine delivered intravenously in hospital and health care settings that were designed to produce a rapid onset of action within two to five minutes. The drug is also said to have fewer side affects than traditional opioids, which is a huge plus. Now the news that more shares have been issued pushed the Trevena Inc price down.

Looking a the chart, the main resistance the bulls need to overcome is at the high of USD 3.63 per share. There is some deccent support under the current price level at the psychological USD 2.00 area and then at the black trendline. Beyond that USD 1.71 was also an area that the price bounced a couple of times, so the bulls may step in there.

Trevena stock forecast upgrade

TRVN stock was also upgraded recently by HC Wainwright raised their price target on the stock from USD 4.00 to USD 5.00 per share. The stock had previously closed at USD 2.69, but opened at USD 3.13. HC Wainwright has a buy rating on the stock and sound very bullish. Trevena shares last traded at USD 2.28, with a volume of 15,808,427 shares. The volume over the last couple of weeks has been the highest it has ever been since the companies IPO.

Author

FXStreet Team

FXStreet

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

Editor's Picks

EUR/USD consolidates below 1.1700 as markets turn risk-averse

EUR/USD struggles to stage a rebound and trades near the lower limit of its weekly range below 1.1700 on Thursday. The US Dollar benefits from the cautious market stance and doesn't allow the pair to gain traction ahead of mid-tier data releases.

GBP/USD stays in red near 1.3450 on broad USD resilience

GBP/USD stays on the back foot after posting losses for two consecutive days and trades near 1.3450 on Thursday. The souring market mood amid simmering geopolitical tensions make it difficult for the pair to gain traction as focus shift to the the US labor market data.

Gold sticks to intraday losses below $4,450; seems vulnerable to slide further

Gold maintains its offered tone in the second half of the day and trades below $4,450 after posting daily losses on Wednesday. The downfall lacks any obvious fundamental catalyst and could be attributed to some follow-through profit-taking ahead of the release of the US Nonfarm Payrolls report on Friday.

Pi Network flashes bearish potential as selling pressure mounts

Pi Network trades above $0.2000 at press time on Thursday, following a nearly 2% decline the previous day. Centralized Exchanges have received 1.90 million PI tokens over the last 24 hours, suggesting risk-off sentiment among holders. The technical outlook for the PI token remains bearish, with a risk of a cross below the 20-day Exponential Moving Average.

2026 economic outlook: Clear skies but don’t unfasten your seatbelts yet

Most years fade into the background as soon as a new one starts. Not 2025: a year of epochal shifts, in which the macroeconomy was the dog that did not bark. What to expect in 2026? The shocks of 2025 will not be undone, but neither will they be repeated.